Concepedia
Statistics
Publications
16
Citations
825
H-Index
15
Active since
2006
Affiliations
Moffitt Cancer Center(Current)
University of South Florida
Molecular Oncology (United States)
University of Florida Health
Sylvester Comprehensive Cancer Center
Michael F. Emmons is an author at Moffitt Cancer Center specializing in medicine, oncology, and molecular oncology.
Publications per year
2006–2023
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry, Rajesh R. Nair, Michael F. Emmons et al. · Molecular Cancer Therapeutics · 2008 · 148 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Fernanda Faião‐Flores, Michael F. Emmons, Michael Durante et al. · Clinical Cancer Research · 2019 · 96 citations
Medicine, Oncology, Pharmacology +17
Cell Adhesion to Fibronectin (CAM-DR) Influences Acquired Mitoxantrone Resistance in U937 Cells
Lori Hazlehurst, Raul F. Argilagos, Michael F. Emmons et al. · Cancer Research · 2006 · 85 citations · Full text
Medicine, Cell Biology, Pharmacology +16
Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Joel G. Turner, Douglas C. Marchion, Jana L. Dawson et al. · Cancer Research · 2009 · 80 citations · Full text
Medicine, Cell Biology, Pharmacology +14
CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo
Joel G. Turner, Jana L. Dawson, Michael F. Emmons et al. · Journal of Cancer · 2013 · 78 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 16